Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)

INTRODUCTION: A clinical trial evaluated ocular hypotensive efficacy and safety of netarsudil 0.02% once daily (QD) relative to ripasudil 0.4% twice daily (BID). METHODS: This was a single-masked, randomized, phase 3, superiority study. Japanese patients were randomized to either the netarsudil 0.02...

Descripción completa

Detalles Bibliográficos
Autores principales: Araie, Makoto, Sugiyama, Kazuhisa, Aso, Kenji, Kanemoto, Koji, Iwata, Ryo, Hollander, David A., Senchyna, Michelle, Kopczynski, Casey C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499948/
https://www.ncbi.nlm.nih.gov/pubmed/37603205
http://dx.doi.org/10.1007/s12325-023-02550-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499948/
https://www.ncbi.nlm.nih.gov/pubmed/37603205
http://dx.doi.org/10.1007/s12325-023-02550-w

Ejemplares similares